“life-sciences” Archives

in
Entry Author Date Location
Evestra Signs Deal with Glemark for Generic Version of NuvaRing 03/01/17 Texas
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
Join Xconomy in June for ‘What’s Hot In Cancer Immunotherapy 2017’ 03/01/17 Seattle
StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells 03/01/17 Texas
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
Medisafe Takes In $14.5M to Help Patients Manage Medications 03/01/17 Boston
Former FDA Commissioners Califf, McClellan Talk Healthcare’s Future 03/01/17 National
FDA Approves Houston Biotech Lexicon’s Carcinoid Syndrome Diarrhea Drug 02/28/17 Texas
With Eye On FDA, Kite Says CAR-T For Lymphoma Holds Up After 6 Months 02/28/17 National
Blood Pressure Drug Trial Results Lift La Jolla Pharma Shares 02/27/17 San Diego
Nonprofit Seeds Exonics to Fund Push For CRISPR Duchenne Treatment 02/27/17 Boston
Advaxis Inks Deal with Sellas to Develop New Cancer Immunotherapy 02/27/17 New York
At Arrakis, Gilman Teams With Biogen Vets to Target RNA With Pills 02/27/17 Boston
BioCrossroads Report: Steady Growth for Life Sciences in Indiana 02/24/17 Indiana
Xenex Gets $38M From Essex Woodlands, Others for Germ-Zapping Robots 02/24/17 Texas
Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections 02/24/17 Raleigh Durham
Trump Policies, Paperwork, & More: Advice for Startup Founders 02/24/17 Wisconsin
Bio Roundup: Trump Backlash, Verdine Plans, Sarepta Sale & More 02/24/17 National
Shares in Exact Sciences Rise on Better-Than-Expected P&L Results 02/23/17 Wisconsin
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Seventh Sense Gets Initial FDA Clearance for Simple Blood-Draw Device 02/23/17 Boston
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
Argos Shares Crater on Futility Finding for Kidney Cancer Therapy 02/22/17 Raleigh Durham
Cidara Antifungal Flunks in Phase 2 Clinical Trial, Sinking Shares 02/21/17 San Diego
After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future 02/21/17 Wisconsin
Cashing in On Duchenne Approval, Sarepta Sells Voucher to Gilead For $125M 02/21/17 Boston
Seattle Week in Review: Life Sciences at Risk, Keiretsu Record, & More 02/17/17 Seattle
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
Dermata Secures $10M in Combined Financing for Skin Treatments 02/17/17 San Diego
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Page 3 of 318 « previous page · next page »